相关实验视频

Updated: Jun 9, 2025

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.2K

目前用于临床实践的骨髓增殖性瘤评分系统

Hélène Pasquer1,2, Jean-Jacques Kiladjian1,3, Lina Benajiba1,2

  • 1Centre d'Investigations Cliniques, INSERM CIC 1427, Hôpital Saint-Louis, Université Paris Cité, Assistance Publique des Hôpitaux de Paris, Paris, France.

Blood
|October 30, 2024
PubMed
概括

准确的风险分层对于管理骨髓增殖性瘤 (MPNs) 至关重要. 本综述将MPN评分系统进行比较,以指导临床决策并改善患者的治疗结果.

更多相关视频

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.6K
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

11.5K

相关概念视频

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K